Literature DB >> 6928791

The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.

E Kurrle, S Bhaduri, H Heimpel, D Hoelzer, D Krieger, E Vanek, B Kubanek.   

Abstract

The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia was studied retrospectively in 47 patients who were treated with a standardized aggressive chemotherapy of daunorubicin and cytosine arabinoside. Twenty-two patients were treated in strict reverse isolation with antimicrobial decontamination and 25 patients in the open ward without any measures against infections. In the patients in isolation the incidence of new infections per patient was 0.77 compared to 1.42 in the control group. The rate of complete remissions was 77% in the patients in isolation vs. 56% in the control patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928791     DOI: 10.1007/bf01008576

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  14 in total

1.  CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963.

Authors:  E M HERSH; G P BODEY; B A NIES; E J FREIREICH
Journal:  JAMA       Date:  1965-07-12       Impact factor: 56.272

2.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

Review 3.  The utility of protected-environment regimens for the compromised host: a critical assessment.

Authors:  P A Pizzo; A S Levine
Journal:  Prog Hematol       Date:  1977

4.  Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.

Authors:  J W Yates; H J Wallace; R R Ellison; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

5.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

6.  Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.

Authors:  G P Bodey; E A Gehan; E J Freireich; E Frei
Journal:  Am J Med Sci       Date:  1971-09       Impact factor: 2.378

7.  A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.

Authors:  J W Yates; J F Holland
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

8.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination.

Authors:  J Dankert; W Gaus; H Gaya; D Krieger; G Linzenmeier; D van der Waaij
Journal:  Infection       Date:  1978       Impact factor: 3.553

9.  Causes of death in adults with acute leukemia.

Authors:  H Y Chang; V Rodriguez; G Narboni; G P Bodey; M A Luna; E J Freireich
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

10.  High remission-induction rate in acute myeloid leukaemia.

Authors:  R P Gale; M J Cline
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

View more
  4 in total

1.  Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.

Authors:  J M Vossen; P J Heidt; H van den Berg; E J Gerritsen; J Hermans; L J Dooren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

2.  Laminar air flow versus barrier nursing in marrow transplant recipients.

Authors:  H K Mahmoud; U W Schaefer; F Schüning; C G Schmidt; M Bamberg; E Haralambie; G Linzenmeier; D Hantschke; H Grosse-Wilde; W Luboldt
Journal:  Blut       Date:  1984-11

3.  [Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures].

Authors:  H Link; H M Frauer; K Wilms; H D Waller
Journal:  Klin Wochenschr       Date:  1983-04-01

4.  Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.

Authors:  N Muis; W A Kamps; J Dankert
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.